CHLA Clinical Research Studies

Having volunteers participate in research studies and clinical trials is critical to our research efforts. Thousands of children and families are involved in our patient-centered studies every year. Many of the treatments used today are based on the results of past research studies and clinical trials conducted with our patients. Our scientific and clinical experts take the best ideas from the laboratory -- to the patient -- in the form of promising new treatments.

By searching our study directory, you may identify research that could impact the life of your child or of another child you know. Because the number of available research studies and clinical trials for children nationwide is small, every participant makes a significant contribution.

In addition to enrolling children with certain diseases in order to study treatments and prevention of those diseases, we also need to study healthy children. Ask your child’s doctor about volunteer study options that may be suitable for your child.

Please contact the study staff listed in your search results for more information.

Search by Keyword:    

Back to the full listing

Study Details - ID: CHLA-20-00511
Health/Science/Disease Category:
ICD9/10 diagnostic codes corresponding with chronic illness/disability from 10 subspecialty clinics
Short Name:
Perceptions of LARC among AYA wth chronic illness
Full Title of Study:
A Qualitative Study of Contraceptive Choice and Decision-making Among Adolescent and Young Adults Living With Chronic Illness and Medical Complexity: a Focus on Long Acting Reversible Contraception (LARC)
Phase/Type of Study:
Qualitative Study
Purpose of Research:
This is an observational study that employs qualitative methods (13 focus groups and 22 individual interviews) targeting 130 sexually active and non-sexually active adolescent and young adult (AYA) females, living with chronic illness or disability. The study is designed to explore the extent to which their experiences living with chronic illness and engagement in ongoing medical management has an impact on their contraception decision making and perception of LARC as a viable option.
Eligibility:
16-21 year old female or transmale (have potential for pregnancy), english speaking patients who have a chronic condition and are receviing ongoing care at CHLA
Time Commitment/Requirements:
6 months, 1 focus group and 1 demographic survey
Primary Investigator:
Claudia Borzutzky, MD & Ellen Iverson, MPH
Coordinator Contact Name:
Jessica Rocha
Phone Number:
(323)361-2416
Email:
jrocha@chla.usc.edu
Clinical Trials .Gov Identifier:
NA